We are live on ! Find out more
EAM

Empirical Asset Management Portfolio holdings

AUM $379M
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
+3.7%
1 Year Est. Return
+24.52%
3 Year Est. Return
+59.99%
5 Year Est. Return
10 Year Est. Return
AUM
$355M
AUM Growth
-$5.58M
Cap. Flow
-$9.36M
Cap. Flow %
-2.64%
Top 10 Hldgs %
23.85%
Holding
387
New
19
Increased
116
Reduced
197
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 16.86%
2 Financials 5.71%
3 Consumer Discretionary 5.37%
4 Communication Services 4.44%
5 Healthcare 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
76
iShares Core S&P Mid-Cap ETF
IJH
$125B
$1.22M 0.34%
18,471
-52
-0.3% -$3.41K
WFC icon
77
Wells Fargo
WFC
$270B
$1.22M 0.34%
13,045
-493
-4% -$42.8K
BAC icon
78
Bank of America
BAC
$442B
$1.18M 0.33%
49,818
+419
+0.8% +$22.1K
IVW icon
79
iShares S&P 500 Growth ETF
IVW
$77.1B
$1.17M 0.33%
9,480
-539
-5% -$66K
EMGF icon
80
iShares Emerging Markets Equity Factor ETF
EMGF
$1.87B
$1.16M 0.33%
20,111
+2,718
+16% +$157K
CLSE icon
81
Convergence Long/Short Equity ETF
CLSE
$843M
$1.16M 0.33%
42,445
+12,382
+41% +$331K
GRMN
82
Garmin
GRMN
$58.3B
$1.14M 0.32%
5,616
-1,019
-15% -$222K
UTHR icon
83
United Therapeutics
UTHR
$22B
$1.13M 0.32%
2,316
-25
-1% -$11.6K
MEDP icon
84
Medpace
MEDP
$16.4B
$1.12M 0.32%
2,003
-186
-8% -$106K
NFLX icon
85
Netflix
NFLX
$309B
$1.11M 0.31%
11,860
+2,430
+26% +$262K
MMM icon
86
3M
MMM
$93.9B
$1.06M 0.3%
6,620
-48
-0.7% -$7.85K
NEM icon
87
Newmont
NEM
$110B
$1.04M 0.29%
10,375
+415
+4% +$37.5K
VUG icon
88
Vanguard Morningstar Growth ETF
VUG
$230B
$1.04M 0.29%
67,614
+60
+0.1% +$4.87K
IDCC icon
89
InterDigital
IDCC
$8.53B
$1.03M 0.29%
3,247
+130
+4% +$46K
MA icon
90
Mastercard
MA
$500B
$1.03M 0.29%
1,807
+328
+22% +$183K
FOXA icon
91
Fox Class A
FOXA
$24.6B
$1.03M 0.29%
14,076
+3,230
+30% +$211K
MRK icon
92
Merck
MRK
$317B
$1.02M 0.29%
12,481
-222
-2% -$20.8K
ORCL icon
93
Oracle
ORCL
$416B
$1.02M 0.29%
7,030
+24
+0.3% +$5.71K
ADBE icon
94
Adobe
ADBE
$103B
$1.01M 0.29%
2,891
-82
-3% -$27.9K
GEW
95
Cambria Global EW ETF
GEW
$145M
$1M 0.28%
19,537
HYZD icon
96
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$260M
$991K 0.28%
43,999
+5,929
+16% +$133K
SCHW
97
Charles Schwab
SCHW
$188B
$989K 0.28%
28,896
+2,218
+8% +$210K
ARM icon
98
Arm
ARM
$293B
$984K 0.28%
9,000
-200
-2% -$29.1K
ROAM icon
99
Hartford Multifactor Emerging Markets ETF
ROAM
$109M
$983K 0.28%
33,743
+11,849
+54% +$342K
GEM icon
100
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.71B
$975K 0.28%
23,420
+8,150
+53% +$339K

Similar funds

Empirical Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Empirical Asset Management held 387 positions worth $355M, down 1.6% from $360M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Empirical Asset Management's Q4 2025 filing shows 19 new, 116 increased, 197 reduced and 31 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 8,218 shares worth $637K. The largest sale was LHA Risk-Managed Income ETF, an estimated $2.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Empirical Asset Management's largest Q4 2025 buy was Vanguard Morningstar Total Stock Market ETF: 8,218 shares worth $637K.
  • Empirical Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $4.06M increase.
  • Empirical Asset Management's biggest Q4 2025 reduction was LHA Risk-Managed Income ETF, cutting an estimated $2.65M.
  • Empirical Asset Management fully exited Lam Research in Q4 2025, selling an estimated $980K.
  • Empirical Asset Management's ten largest holdings make up 24% of its $355M portfolio in Q4 2025.
  • Empirical Asset Management opened 19 new positions and closed 31 in Q4 2025.
  • Empirical Asset Management's portfolio value fell 1.6% quarter-over-quarter to $355M.

Based on Empirical Asset Management's 13F filing for Q4 2025, filed 6 Feb 2026.